MCID: ACR006
MIFTS: 55

Aceruloplasminemia malady

Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Metabolic diseases, Blood diseases categories

Summaries for Aceruloplasminemia

About this section


NIH Rare Diseases:41 Aceruloplasminemia is a disorder of iron metabolism. this disorder causes iron to build-up in the body. signs and symptoms begin in adulthood. people with this disorder tend to develop anemia and diabetes in their 20's. as the condition progresses, movement problems are common, such as tremors, chorea, ataxia, eyelid twitching, and grimacing. some experience psychiatric problems and dementia in their 40's and 50's. eye examination may reveal changes in the retina, but these changes typically do not affect vision. aceruloplasminemia is caused by mutations in the cp gene and are inherited in an autosomal recessive fashion. last updated: 8/3/2011

MalaCards based summary: Aceruloplasminemia, also known as familial apoceruloplasmin deficiency, is related to hemosiderosis and retinal degeneration, and has symptoms including retinopathy, diabetes mellitus and tremor. An important gene associated with Aceruloplasminemia is CP (ceruloplasmin (ferroxidase)), and among its related pathways are HIF-1-alpha transcription factor network and Mechanisms of CFTR activation by S nitrosoglutathione normal and CF . The compounds ferrozine and ferrous ammonium sulfate have been mentioned in the context of this disorder. Affiliated tissues include retina, brain and eye, and related mouse phenotypes are pigmentation and cardiovascular system.

Disease Ontology:9 An iron metabolism disease that has material basis in a mutation in the ceruloplasmin gene characterized by progressive neurodegeneration of the retina and basal ganglia and diabetes mellitus.

Genetics Home Reference:21 Aceruloplasminemia is a disorder in which iron gradually accumulates in the brain and other organs. Iron accumulation in the brain results in neurological problems that generally appear in adulthood and worsen over time.

Wikipedia:63 Aceruloplasminemia is a rare autosomal recessive disorder in which iron gradually accumulates in the... more...

GeneReviews summary for acp

Aliases & Classifications for Aceruloplasminemia

About this section
Sources:
9Disease Ontology, 63Wikipedia, 19GeneReviews, 41NIH Rare Diseases, 20GeneTests, 21Genetics Home Reference, 11DISEASES, 47Orphanet, 60UMLS, 22GTR, 34MESH via Orphanet, 26ICD10 via Orphanet
See all sources

Aceruloplasminemia, Aliases & Descriptions:

Name: Aceruloplasminemia 9 63 19 41 20 21 11 47
Familial Apoceruloplasmin Deficiency 41 21 60
Hereditary Ceruloplasmin Deficiency 41 21 47
Systemic Hemosiderosis Due to Aceruloplasminemia 41 21
 
Deficiency of Ferroxidase 21 22
Ceruloplasmin Deficiency 41 60
Hypoceruloplasminemia 41 21


Classifications:



Characteristics (Orphanet epidemiological data):

47
aceruloplasminemia:
Inheritance: Autosomal recessive; Prevalence: 1-9/1000000 (Japan),<1/1000000 (Worldwide); Age of onset: Adult; Age of death: elderly


External Ids:

Disease Ontology9 DOID:0050711
Orphanet47 48818
MESH via Orphanet34 C536004
ICD10 via Orphanet26 G23.0

Related Diseases for Aceruloplasminemia

About this section

Diseases related to Aceruloplasminemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 49)
idRelated DiseaseScoreTop Affiliating Genes
1hemosiderosis30.8CP, TF
2retinal degeneration30.5PANK2, HEPH, CP
3neurodegeneration with brain iron accumulation 130.3PANK2, FA2H
4siderosis30.2TF, CP
5hepatitis30.1TFR2, TF
6wilson disease29.9TF, CP, SOD1
7hemochromatosis29.4TF, TFR2, HEPH, HFE2, CP, HAMP
8eales disease10.4SOD1
9hemochromatosis type 210.4HAMP, HFE2
10choreoacanthocytosis10.3PANK2, CP
11porphyria cutanea tarda10.3TF
12movement disease10.3PANK2, CP
13blepharospasm10.3
14pneumoconiosis10.3CP, SOD1
15cerebellar ataxia10.2
16menkes disease10.2SOD1, CP
17dementia10.2
18anemia, hypochromic microcytic10.1TF, CP
19iron metabolism disease10.1TF, HFE2
20iron deficiency anemia10.1HEPH, TF
21thalassemia, hispanic gamma-delta-beta10.1TFR2, TF
22thalassemia10.1TF, HAMP
23hypogonadism10.1TF
24galactosemia10.1CP, TF
25ataxia10.1
26motor neuron disease10.0SOD2, SOD1
27hemolytic anemia10.0TF, CP
28non-suppurative otitis media10.0TF, CP, HFE2
29schizophrenia10.0
30obesity10.0
31diabetes insipidus10.0
32neuronitis10.0
33cerebritis10.0
34hypothyroidism10.0
35retinitis10.0
36superficial siderosis10.0
37nutritional deficiency disease10.0TF, CP
38liver cirrhosis10.0TF, CP, TFR2
39microvascular complications of diabetes 510.0SOD2, SOD1
40atransferrinemia10.0HEPH, TF, TFR2
41parkinson disease, late-onset9.9SOD1, CP, SOD2
42uremia9.9SOD1, TF
43cork-handlers' disease9.9SOD2, TF
44brain disease9.9TF, CP, SOD2
45liver disease9.8SOD2, HAMP, TF
46alcoholic liver cirrhosis9.8SOD1, SOD2, TF
47hepatitis c9.7TF, HAMP, TFR2, SOD2
48diabetes mellitus, insulin-dependent9.6SOD1, CP, SOD2, TF
49deficiency anemia9.3TFR2, HAMP, HFE2, HEPH, SOD2, CP

Graphical network of the top 20 diseases related to Aceruloplasminemia:



Diseases related to aceruloplasminemia

Symptoms for Aceruloplasminemia

About this section

Symptoms:

 47 (show all 20)
  • retinopathy
  • pollakiuria/polyuria/dysuria/anuria/acute urine retention/oliguria
  • diabetes mellitus
  • tremor
  • chorea/athetosis/choreoathetosis/choreic syndrome
  • anaemia
  • hyperferritinemia/iron overload
  • autosomal recessive inheritance
  • ataxia/incoordination/trouble of the equilibrium
  • dystonia/torticollis/writer's cramp/blepharospasms
  • execution movement disorder/dysmetria/bradykinesia/akinesia/apraxia
  • hypertonia/spasticity/rigidity/stiffness
  • speech troubles/aphasia/dysphasia/echolalia/mutism/logorrhea/dysprosodia
  • psychic/psychomotor regression/dementia/intellectual decline
  • psychic/behavioural troubles
  • humour troubles/anxiety/depression/apathy/euphoria/irritability
  • heart/cardiac failure
  • hypothyroidy
  • elocution disorders/dysarthria/dysphonia
  • troubles of memory/amnesia/hypermnesia

HPO human phenotypes related to Aceruloplasminemia:

(show all 16)
id Description Frequency HPO Source Accession
1 retinopathy hallmark (90%) HP:0000488
2 diabetes mellitus hallmark (90%) HP:0000819
3 tremor hallmark (90%) HP:0001337
4 anemia hallmark (90%) HP:0001903
5 chorea hallmark (90%) HP:0002072
6 abnormality of iron homeostasis hallmark (90%) HP:0011031
7 abnormal renal physiology hallmark (90%) HP:0012211
8 behavioral abnormality typical (50%) HP:0000708
9 hypertonia typical (50%) HP:0001276
10 neurological speech impairment typical (50%) HP:0002167
11 incoordination typical (50%) HP:0002311
12 developmental regression typical (50%) HP:0002376
13 hypothyroidism occasional (7.5%) HP:0000821
14 congestive heart failure occasional (7.5%) HP:0001635
15 neurological speech impairment occasional (7.5%) HP:0002167
16 memory impairment occasional (7.5%) HP:0002354

Drugs & Therapeutics for Aceruloplasminemia

About this section

Drug clinical trials:

Search ClinicalTrials for Aceruloplasminemia

Search NIH Clinical Center for Aceruloplasminemia

Genetic Tests for Aceruloplasminemia

About this section

Genetic tests related to Aceruloplasminemia:

id Genetic test Affiliating Genes
1 Aceruloplasminemia20 CP
2 Deficiency of Ferroxidase22

Anatomical Context for Aceruloplasminemia

About this section

MalaCards organs/tissues related to Aceruloplasminemia:

31
Retina, Brain, Eye, Heart, Liver

Animal Models for Aceruloplasminemia or affiliated genes

About this section

MGI Mouse Phenotypes related to Aceruloplasminemia:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011868.6HEPH, SOD2, CP
2MP:00053858.0SOD1, SOD2, CP, HFE2, HEPH
3MP:00053917.5FA2H, SOD2, CP, SOD1, PANK2, HEPH
4MP:00036317.4HEPH, PANK2, FA2H, SOD2, CP, SOD1
5MP:00053707.4HEPH, SOD1, HFE2, TFR2, CP, PANK2
6MP:00053877.0HAMP, CP, SOD2, SOD1, PANK2, HEPH
7MP:00053976.6TF, HFE2, HEPH, PANK2, SOD2, CP
8MP:00053766.2FA2H, HEPH, PANK2, SOD1, SOD2, CP

Publications for Aceruloplasminemia

About this section

Articles related to Aceruloplasminemia:

(show top 50)    (show all 68)
idTitleAuthorsYear
1
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia. (25864092)
2015
2
Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series. (25661792)
2015
3
Superficial siderosis associated with aceruloplasminemia. Case report. (24607334)
2014
4
Aceruloplasminemia. (25168455)
2014
5
Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey. (25247888)
2014
6
Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms. (23557349)
2013
7
Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia. (24218322)
2013
8
Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score. (24002824)
2013
9
Aceruloplasminemia: an update. (24209437)
2013
10
Case of presymptomatic aceruloplasminemia treated with deferasirox. (24341521)
2013
11
Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation. (23812204)
2013
12
Aceruloplasminemia. (22515740)
2012
13
Criteria for early identification of aceruloplasminemia. (21720062)
2011
14
Desferrioxamine treatment of aceruloplasminemia: Long-term follow-up. (21594898)
2011
15
Aceruloplasminemia: a rare disease - diagnosis and treatment of two cases. (23049345)
2011
16
Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation. (20801540)
2010
17
Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia. (20686294)
2010
18
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability. (18200628)
2008
19
Redox active iron accumulation in aceruloplasminemia. (18282164)
2008
20
Aceruloplasminemia: a case report. (18408989)
2008
21
Cys-881 is essential for the trafficking and secretion of truncated mutant ceruloplasmin in aceruloplasminemia. (17637479)
2007
22
Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis. (17508145)
2007
23
Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate. (17307325)
2007
24
Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia. (17710675)
2007
25
Molecular and pathological basis of aceruloplasminemia. (16629161)
2006
26
Aceruloplasminemia (hereditary ceruloplasmin deficiency) and diabetes mellitus]. (17022509)
2006
27
Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia. (16831606)
2006
28
Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia. (16599945)
2006
29
MR imaging of cerebral cortical involvement in aceruloplasminemia. (15760883)
2005
30
Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. (15105274)
2004
31
Aceruloplasminemia, an inherited disorder of iron metabolism. (12572680)
2003
32
Aceruloplasminemia, an iron metabolic disorder. (14719552)
2003
33
Aceruloplasminemia. (12614942)
2003
34
Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. (12879954)
2003
35
Not all absent serum ceruloplasmin is Wilson disease: a review of aceruloplasminemia. (12227652)
2002
36
The copper-iron connection: hereditary aceruloplasminemia. (12382203)
2002
37
Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. (12071349)
2002
38
Biochemical analysis of a missense mutation in aceruloplasminemia. (11689569)
2002
39
Defective electron transfer in complexes I and IV in patients with aceruloplasminemia. (11102640)
2000
40
Increased lipid peroxidation in the brains of aceruloplasminemia patients. (10831768)
2000
41
Aceruloplasminemia with a novel mutation associated with parkinsonism. (10983721)
2000
42
Estimation of the gene frequency of aceruloplasminemia in Japan. (10449129)
1999
43
CSF abnormalities in patients with aceruloplasminemia. (9781556)
1998
44
Aceruloplasminemia. (9727700)
1998
45
Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. (9443469)
1998
46
Use of desferrioxamine in the treatment of aceruloplasminemia. (9066364)
1997
47
Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. (8968753)
1996
48
Late onset diabetes mellitus in patients with hereditary aceruloplasminemia. (8894739)
1996
49
Increased plasma lipid peroxidation in patients with aceruloplasminemia. (8721620)
1996
50
Aceruloplasminemia (20301666)
1993

Variations for Aceruloplasminemia

About this section

Clinvar genetic disease variations for Aceruloplasminemia:

6 (show all 42)
id Gene Variation Type Significance SNP ID Assembly Location
1CPNM_000096.3(CP): c.3019-1G> Asingle nucleotide variantPathogenicrs386134142GRCh37Chr 3, 148894200: 148894200
2CPNM_000096.3(CP): c.2389delG (p.Glu797Argfs)deletionPathogenicrs386134149GRCh37Chr 3, 148901289: 148901289
3CPNM_000096.3(CP): c.1286_1287insTACAC (p.Asp430Thrfs)insertionPathogenicrs386134145GRCh37Chr 3, 148919950: 148919951
4CPNM_000096.3(CP): c.2630G> A (p.Trp877Ter)single nucleotide variantPathogenicrs121909579GRCh37Chr 3, 148897374: 148897374
5CPNM_000096.3(CP): c.606dupA (p.Asp203Argfs)duplicationPathogenicrs386134143GRCh37Chr 3, 148927955: 148927955
6CPNM_000096.3(CP): c.1049C> A (p.Ala350Asp)single nucleotide variantPathogenicrs386134127GRCh37Chr 3, 148924114: 148924114
7CPNM_000096.3(CP): c.229G> C (p.Asp77His)single nucleotide variantPathogenicrs200683433GRCh37Chr 3, 148930403: 148930403
8CPNM_000096.3(CP): c.650T> C (p.Phe217Ser)single nucleotide variantPathogenicrs386134125GRCh37Chr 3, 148927129: 148927129
9CPNM_000096.3(CP): c.1874G> A (p.Gly625Glu)single nucleotide variantPathogenicrs386134129GRCh37Chr 3, 148904510: 148904510
10CPNM_000096.3(CP): c.2675G> A (p.Gly892Glu)single nucleotide variantPathogenicrs386134131GRCh37Chr 3, 148896405: 148896405
11CPNM_000096.3(CP): c.2684G> C (p.Gly895Ala)single nucleotide variantPathogenicrs139633388GRCh37Chr 3, 148896396: 148896396
12CPNM_000096.3(CP): c.2962G> A (p.Gly988Ser)single nucleotide variantPathogenicrs386134133GRCh37Chr 3, 148895683: 148895683
13CPNM_000096.3(CP): c.548T> C (p.Ile183Thr)single nucleotide variantPathogenicrs386134123GRCh37Chr 3, 148928013: 148928013
14CPNM_000096.3(CP): c.82A> T (p.Ile28Phe)single nucleotide variantPathogenicrs386134121GRCh37Chr 3, 148939498: 148939498
15CPNM_000096.3(CP): c.2953A> G (p.Met985Val)single nucleotide variantPathogenicrs386134132GRCh37Chr 3, 148895692: 148895692
16CPNM_000096.3(CP): c.587C> G (p.Pro196Arg)single nucleotide variantPathogenicrs386134124GRCh37Chr 3, 148927974: 148927974
17CPNM_000096.3(CP): c.493C> G (p.Gln165Glu)single nucleotide variantPathogenicrs386134122GRCh37Chr 3, 148928068: 148928068
18CPNM_000096.3(CP): c.2131C> A (p.Gln711Lys)single nucleotide variantPathogenicrs386134130GRCh37Chr 3, 148903180: 148903180
19CPNM_000096.3(CP): c.643C> T (p.Arg215Ter)single nucleotide variantPathogenicrs386134155GRCh37Chr 3, 148927136: 148927136
20CPNM_000096.3(CP): c.2158C> T (p.Arg720Trp)single nucleotide variantPathogenicrs145784949GRCh37Chr 3, 148903153: 148903153
21CPNM_000096.3(CP): c.2701C> T (p.Arg901Ter)single nucleotide variantPathogenicrs386134156GRCh37Chr 3, 148896379: 148896379
22CPNM_000096.3(CP): c.1652C> T (p.Thr551Ile)single nucleotide variantPathogenicrs61733458GRCh37Chr 3, 148916215: 148916215
23CPNM_000096.3(CP): c.848G> C (p.Trp283Ser)single nucleotide variantPathogenicrs386134126GRCh37Chr 3, 148925338: 148925338
24CPNM_000096.3(CP): c.1123T> C (p.Tyr375His)single nucleotide variantPathogenicrs386134128GRCh37Chr 3, 148924040: 148924040
25CPNM_000096.3(CP): c.1209-2A> Gsingle nucleotide variantPathogenicrs386134137GRCh37Chr 3, 148920030: 148920030
26CPNM_000096.3(CP): c.1209_1210dupTG (p.Asp404Valfs)duplicationPathogenicrs386134138GRCh37Chr 3, 148920026: 148920027
27CPNM_000096.3(CP): c.1257_1258delTT (p.Tyr420Terfs)deletionPathogenicrs386134144GRCh37Chr 3, 148919979: 148919980
28CPNM_000096.3(CP): c.146+1G> Asingle nucleotide variantPathogenicrs386134134GRCh37Chr 3, 148939433: 148939433
29CPNM_000096.3(CP): c.1865-1G> Asingle nucleotide variantPathogenicrs386134139GRCh37Chr 3, 148904520: 148904520
30CPNM_000096.3(CP): c.1918delG (p.Asp640Ilefs)deletionPathogenicrs386134146GRCh37Chr 3, 148904466: 148904466
31CPNM_000096.3(CP): c.2065delC (p.Pro689Leufs)deletionPathogenicrs386134147GRCh37Chr 3, 148904319: 148904319
32CPNM_000096.3(CP): c.2068delG (p.Asp690Thrfs)deletionPathogenicrs386134148GRCh37Chr 3, 148904316: 148904316
33CPNM_000096.3: p.Leu729Trpfs*40deletionPathogenic
34CPNM_000096.3(CP): c.2482delG (p.Ala828Profs)deletionPathogenicrs386134150GRCh37Chr 3, 148899864: 148899864
35CPNM_000096.3(CP): c.2511dupT (p.Gly838Trpfs)duplicationPathogenicrs386134151GRCh37Chr 3, 148899835: 148899836
36CPNM_000096.3(CP): c.2554+1G> Tsingle nucleotide variantPathogenicrs386134140GRCh37Chr 3, 148899791: 148899791
37CPNM_000096.3(CP): c.2602delG (p.Gly868Glufs)deletionPathogenicrs386134152GRCh37Chr 3, 148897402: 148897402
38CPNM_000096.3(CP): c.2689_2690delCT (p.Leu897Aspfs)deletionPathogenicrs386134153GRCh37Chr 3, 148896390: 148896391
39CPNM_000096.3(CP): c.2879-1G> Asingle nucleotide variantPathogenicrs386134141GRCh37Chr 3, 148895767: 148895767
40CPNM_000096.3(CP): c.2917dupA (p.Thr973Asnfs)duplicationPathogenicrs386134154GRCh37Chr 3, 148895727: 148895728
41CPNM_000096.3(CP): c.395-1G> Asingle nucleotide variantPathogenicrs386134135GRCh37Chr 3, 148928167: 148928167
42CPNM_000096.3(CP): c.607+1G> Asingle nucleotide variantPathogenicrs386134136GRCh37Chr 3, 148927953: 148927953

Expression for genes affiliated with Aceruloplasminemia

About this section
Search GEO for disease gene expression data for Aceruloplasminemia.

Pathways for genes affiliated with Aceruloplasminemia

About this section

Compounds for genes affiliated with Aceruloplasminemia

About this section
Sources:
43Novoseek, 24HMDB, 12DrugBank, 49PharmGKB
See all sources

Compounds related to Aceruloplasminemia according to GeneCards Suite gene sharing:

(show top 50)    (show all 73)
idCompoundScoreTop Affiliating Genes
1ferrozine4310.1CP, TF
2ferrous ammonium sulfate4310.1TF, CP
3apotransferrin4310.0CP, TF
4ferric ammonium citrate4310.0TF, CP
5dmpo-oh4310.0CP, SOD1
6randox4310.0CP, SOD1
7thiobarbituric acid439.9CP, SOD1
8carnosine43 2410.8SOD1, CP
9mntmpyp439.8SOD1, SOD2
10lutein439.8CP, SOD2
11sodium azide439.8SOD1, CP
12azide439.8CP, SOD1
13pyrogallol439.8SOD1, SOD2
14zinc superoxide439.8SOD1, SOD2
15propyl gallate439.8SOD1, SOD2
163-nitrotyrosine439.7SOD2, SOD1
17glutathion439.7SOD2, SOD1
183-amino-1,2,4-triazole439.7SOD1, SOD2
19onoo439.7SOD2, SOD1
20dmpo439.6SOD2, SOD1, CP
21antimycin a439.5SOD1, SOD2
22dicoumarol439.5SOD2, SOD1
23hypoxanthine43 24 1211.5SOD2, CP, SOD1
24malondialdehyde439.5CP, SOD1, SOD2
25pdtc439.5SOD1, SOD2, CP
26suprofen43 1210.5TF, CP, SOD1
27dtpa439.5SOD1, CP, TF
28citrate439.5SOD2, CP, TF
29levodopa43 1210.4TF, CP, SOD1
30trolox439.4SOD1, SOD2
31allopurinol43 49 1211.4SOD2, SOD1
32folate439.4CP, TF, SOD2
338-oxo-dg439.3SOD2, SOD1
34selenite439.3TF, SOD1, SOD2
35adriamycin439.2SOD1, SOD2, TF
36deferoxamine43 1210.1CP, TFR2, TF, SOD1
37fenton439.0SOD1, CP, TF, SOD2
38dehydroascorbic acid43 1210.0TF, CP, SOD1, SOD2
39tocopherol439.0CP, SOD2, TF, SOD1
40selenium43 2410.0SOD2, SOD1, CP, TF
41betacarotene439.0TF, SOD2, SOD1, CP
42alpha tocopherol439.0SOD2, CP, SOD1, TF
43sodium nitroprusside439.0SOD2, CP, TF, SOD1
44vitamin a43 24 1211.0TF, SOD1, SOD2, CP
45ascorbic acid43 2410.0SOD2, CP, SOD1, TF
46lactate438.9TF, SOD2, SOD1, CP
47agar438.9TF, CP, SOD2
48creatinine438.7CP, TF, SOD2, HAMP, SOD1
49copper43 249.2SOD1, HEPH, SOD2, CP, TF
50iron43 246.9SFXN1, HAMP, TF, TFR2, CP, SOD2

GO Terms for genes affiliated with Aceruloplasminemia

About this section

Cellular components related to Aceruloplasminemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial intermembrane spaceGO:00057589.5PANK2, SOD1
2extracellular spaceGO:00056158.4HFE2, SOD1, CP, TF

Biological processes related to Aceruloplasminemia according to GeneCards Suite gene sharing:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1iron ion transportGO:00068269.8TFR2, SFXN1
2peripheral nervous system myelin maintenanceGO:00322879.7SOD1, FA2H
3response to superoxideGO:00003039.7SOD1, SOD2
4hydrogen peroxide biosynthetic processGO:00506659.6SOD2, SOD1
5removal of superoxide radicalsGO:00194309.6SOD2, SOD1
6superoxide anion generationGO:00425549.6SOD2, SOD1
7copper ion transportGO:00068259.5HEPH, CP
8superoxide metabolic processGO:00068019.5SOD1, SOD2
9iron ion homeostasisGO:00550729.5SFXN1, HFE2, SOD2
10response to axon injuryGO:00486789.5SOD1, SOD2
11regulation of blood pressureGO:00082179.4SOD1, SOD2
12retina homeostasisGO:00018959.3TF, SOD1
13regulation of mitochondrial membrane potentialGO:00518819.3SOD2, SOD1, PANK2
14glutathione metabolic processGO:00067499.3SOD2, SOD1
15response to hydrogen peroxideGO:00425429.1SOD2, SOD1
16cellular iron ion homeostasisGO:00068797.9HEPH, SOD1, CP, TFR2, HAMP, TF

Molecular functions related to Aceruloplasminemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1chaperone bindingGO:00510879.6SOD1, CP
2superoxide dismutase activityGO:00047849.1SOD1, SOD2
3copper ion bindingGO:00055078.6HEPH, SOD1, CP

Products for genes affiliated with Aceruloplasminemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Aceruloplasminemia

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet